cancer research News
-
AACR (American Association of Cancer Research) 2020
This venue was postponed until further notice. We are going to present our TMS for the 10th time during the 2020 AACR in San Diego (April 26th- April 29th). Please visit Biopticon at Booth # ...
-
AACR (American Association of Cancer Research) 2019
We are going to present our TMS for the 9th time during the 2019 AACR in Atlanta (March 29th– April 3rd). Please visit Biopticon at Booth # ...
-
AACR (American Association of Cancer Research) 2018
This is our 8th year at the show. We would be happy to show you our new imager, TumorImager-2TM. Please visit us at our booth ...
-
Collaboration with LOVIT/ Dr. Antonio Marchini
Redbiotec is pleased to announce the appointment of Dr. Antonio Marchini, head of Laboratory of Oncolytic-Virus-Immuno-Therapeutics (LOVIT) at the Luxembourg Institute of Health and German Cancer Research Center (DKFZ), as a member of our Scientific Advisory Board. Antonio is an expert in the field of oncolytic viruses aiming at developing innovative anticancer agents. Redbiotec looks forward to ...
By Redbiotec AG
-
Saks fifth avenue`s limited edition t-shirt designed by Donna Karan worn by ambassador Uma Thurman is available in stores now
Saks Fifth Avenue's limited edition T-shirt created by celebrated designer Donna Karan exclusively to benefit KEY TO THE CURE is now available at Saks Fifth Avenue stores, Saks Fifth Avenue OFF 5TH stores and on saks.com. The shirt retails for $35 with one hundred percent of the proceeds from each shirt sold will be donated to local charity partners. "Everyone I know has been affected by breast ...
-
VMI Raises more than 86,000 Euro with Stelvio for Life
A team of 47 VMI colleagues from Epe and Leszno participated in the Stelvio for Life challenge on Saturday, September 3rd. With this, they raised over 86,000 Euros in the fight against cancer. VMI Raises Funds for Cancer Charity Each year, VMI participates in a challenging sporting event to raise money for charity. After 2 years of not being able to participate in such a fund aising event, the ...
-
CASELLA CHOOSES CANCER RESEARCH UK AS CHARITY PARTNER
As Casella Measurement launches its new Corporate Social Responsibility (CSR) Policy, it is particularly apt that the specialist in occupational health and environmental monitoring equipment has chosen Cancer Research UK as its charity partner, since use of the company’s dust measuring devices play an important part in the fight against lung cancer. The link with the charity is also seen ...
-
Biopticon at American Association of Cancer Research, April 1-5, 2017, in Washington DC
Visit us at our booth #942 Washington DC, April 1-5, 2017 Biopticon will be in Washington DC for the annual 2017 AACR convention. Visit us at our booth Biopticon Corporation ...
-
Intelex`s own `Mo Bros` raise over $5,000 for prostate cancer research
This is my first year with Intelex and what better way to get to know my fellow coworkers than by growing moustaches together? Yes, that’s right: the Intelex family participated in this year’s Movember. Ah, how my upper lip does miss its fuzzy warmth (sadly I had to say goodbye to it on December 1st). In addition to Intelexians raising $2,635 throughout the month of November to ...
-
Agilent Technologies Introduces Two Innovative Products to Advance Clinical Cancer Research
Agilent Technologies Inc. (NYSE: A) today launched two new products-the HaloPlexHS target enrichment system and ClearSeq Comprehensive Cancer research panel-designed to improve the speed and accuracy of clinical cancer research. Both products will enable researchers to rapidly and accurately identify disease-associated variants in tumor samples-information that can be vital to research in cancer ...
-
Neil Hayes, GeneCentric co-founder, highlighted for his work and upcoming AACR presentation by UTHSC where he is the Director of the Center for Cancer Research.
For two decades, scientists have been able to identify the molecular signature of specific cancers by isolating the RNA, responsible for dictating which proteins are produced and, by extension, how the cells behave in the body. Now, Neil Hayes, MD, MS, MPH, director of the Center for Cancer Research at the University of Tennessee Health Science Center, and a colleague at Washington University in ...
-
Comet Assay IV at the forefront of cancer research
Shown below are findings from some recent papers using Comet assay IV (http://www.scorecomets.com) for scoring comet assay slides: Investigations into Xanthohumol, a hop derived prenylated flavonoid found in beer, suggest that it protects against DNA damage induced by a common cooked food mutagen in rat colon mucosa and liver cells [1]. A small clinical study in healthy adult volunteers ...
By Instem Group
-
Lineage and Cancer Research UK Announce Completion of Patient Enrollment in Phase 1 Clinical Study of VAC2 for the Treatment of Non-small Cell Lung Cancer
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Cancer Research UK recently completed patient enrollment in the ongoing Phase 1 clinical trial of VAC2, an allogeneic cancer vaccine product candidate, for the treatment of non-small cell lung cancer ...
-
Imaxio signs an option for a license agreement with the German Cancer Research Center (DKFZ)
Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed. The DKFZ is to make an internal evaluation of Imaxio’s IMX313 pro-immunogenic ...
By IMAXIO S.A.
-
Cancer Research UK Dose First Patient in Phase I/IIa Trial of Lung Cancer Immunotherapy Vaccine
OXFORD, United Kingdom, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Cancer Research UK, Vaccitech plc (Nasdaq: VACC) and the Ludwig Institute for Cancer Research (Ludwig), today announce the first patient dosed in the MAGE trial, which is testing a novel immunotherapeutic, VTP-600, in patients with the most common type of lung cancer. The phase I/IIa trial is expected to enroll approximately 86 people who ...
-
Charity stores feel the pinch as clothing donations fall
The volume of clothing that is being donated to charity stores has reduced significantly but the number of sales has increased, according to the Association of Charity Shops. Head of policy and public affairs David Moir told MRW: “There has been a reduction in the quantity and in the quality of donations which is related to the economic downturn. People are not buying new goods and are less ...
-
Recognizing 10 years of philanthropic support for prostate cancer research
Two powerhouse researchers in prostate cancer will change the way we treat the disease, thanks to funding from legendary volunteer fundraisers, the Bird Dogs and the Alberta Cancer Foundation. Working with the Alberta Cancer Foundation and the University of Alberta, the Bird Dogs have enabled a new one-term, five-year chair position to further prostate cancer research — the Bird Dogs ...
-
Cannabis Sequencing and New Cancer Research
In 2014, the entire genome of Cannabis stavia L. was sequenced. This news received national attention with eye-catching headlines such as: “Marijuana Genome Sequenced for Health, Not Highs”. Researchers and oncologists took note, not due to the attention-grabbing headlines, but because their focus was to pair the decoded cannabis genome research with sequencing of the ...
-
Seventh generation partners with Ovarian Cancer Research Fund to honor ovarian cancer awareness month
The second annual "Let's Talk... Period" campaign honors and supports September as Ovarian Cancer Awareness Month. Seventh Generation, maker of organic cotton tampons, created "Let's Talk... Period" in support of Ovarian Cancer Research Fund (OCRF), the leading organization dedicated to eradicating ovarian cancer, to provide ovarian cancer education and raise funds to support women fighting the ...
-
Creative BioMart Provides a Wide Range of Centromere Proteins for Research Use
Creative BioMart, a world leading biotech company specialized in providing quality protein products and services to customers all over the world now provides a wide selection of centromere proteins for cancer research. Centromeres are specialized DNA sequences in chromosomes, which hold two daughter chromatids together. Centromeres represent a contractile region of the chromosome in which two ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you